October 2013
-
October 2013Helping the heart repair itself after a heart attack has been an elusive goal. A new trial takes a novel approach by genetically boosting a patient’s own stem cells.
-
October 2013The Heart Institute Presentations and Activities Schedule is available for download (pdf).
-
October 2013Accreditation Canada has selected four Heart Institute programs as exemplary Leading Practices for the management and prevention of heart disease.
-
October 2013Pulmonary hypertension is a debilitating disease that must be caught early to be cured. An international survey of clinics is planned to gather and share best practices.
-
October 2013Building hospital facilities takes in-depth planning and stakeholder consultation. As the planning phase ends, the time to break ground for the Heart Institute’s expansion draws closer.
-
October 2013Dr. Thierry Mesana discusses the future of cardiovascular care, the importance of research and what makes the Heart Institute special.
-
October 2013The Heart Institute has 40 expert clinical talks and research presentations at this year’s American Heart Association Scientific Sessions, the largest meeting on heart disease in the world. See the program guide for details.
-
October 2013Read detailed coverage of CCC 2013 highlights—from the importance of exercise as medicine to regenerative stem cell therapy, from aging blood vessels to diabetes management. With nearly 120 Heart Institute program items, it was a busy event.
-
October 2013Transcatheter aortic valve implantation (TAVI) patients tend to be older than most cardiac patients and thus more likely to be frail. Assessment of frailty may hold value in predicting patient outcomes.
-
October 2013
-
October 2013For patients experiencing an ST-elevation myocardial infarction (STEMI), the most dangerous type of heart attack, treatment in a dedicated regional program saves lives. However the benefit specifically to elderly STEMI patients—aged 75 or older—from rapid treatment has not been clear.
-
October 2013In a randomized clinical trial, a Heart Institute group led by Bob Reid, PhD evaluated a program designed to impact the heart health of family members of patients with heart disease. “Family members of patients are in a teachable moment that gives us the opportunity to prevent them from becoming the patients of tomorrow,” said Dr. Reid, Deputy Chief of the Division of Prevention and Rehabilitation.
-
October 2013The promise and challenges of cardiac regenerative medicine—facilitating the growth of new tissue to repair damage to the heart following a heart attack—received wide attention at CCC/Vascular 2013. The labs of University of Ottawa Heart Institute researchers Darryl Davis, MD and Erik Suuronen, PhD, were responsible for more than 20 presentations highlighting their continued progress in this area.
-
October 2013In a Canadian Cardiovascular Society featured program item, cardiologist Thais Coutinho, MD, a recent Heart Institute recruit from the Mayo Clinic, presented interesting findings on arterial stiffness and hypertension. Globally, hypertension is the leading risk factor for death, yet only about half of individuals with high blood pressure have it properly controlled.
-
October 2013People with Type D personality are distressed. They tend to experience negative emotions and keep these emotions inside, not sharing them with others. Personality traits such as these are considered stable over time. As would be expected, Type D individuals with cardiovascular disease have a poor prognosis.
-
October 2013In two lively talks, Peter Liu, MD, Scientific Director of the University of Ottawa Heart Institute, took a big picture point of view. In his plenary presentation to the Vascular Summit, Dr. Liu highlighted the inextricable link between vascular health and aging.
-
October 2013